105 related articles for article (PubMed ID: 8668663)
1. FK506 (tacrolimus) and its immunoreactive metabolites in whole blood of liver transplant patients and subjects with mild hepatic dysfunction.
Tokunaga Y; Alak AM
Pharm Res; 1996 Jan; 13(1):137-40. PubMed ID: 8668663
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus analysis: a comparison of different methods and matrices.
Warty V; Zuckerman S; Venkataramanan R; Lever J; Chao J; Mckaveney T; Fung J; Starzl T
Ther Drug Monit; 1995 Apr; 17(2):159-67. PubMed ID: 7542809
[TBL] [Abstract][Full Text] [Related]
4. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
Minematsu T; Sugiyama E; Kusama M; Hori S; Yamada Y; Ohtani H; Sawada Y; Sato H; Takayama T; Sugawara Y; Makuuchi M; Iga T
Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372
[TBL] [Abstract][Full Text] [Related]
5. FK506 measurement: comparison of different analytical methods.
Warty V; Zuckerman S; Venkataramanan R; Lever J; Fung J; Starzl T
Ther Drug Monit; 1993 Jun; 15(3):204-8. PubMed ID: 7687389
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CEDIA FK506 assay with HPLC/MS/MS in a large cohort of pediatric patients.
Lower DR; Cropcho L; Rosendorff A
Am J Clin Pathol; 2013 Jun; 139(6):788-92. PubMed ID: 23690122
[TBL] [Abstract][Full Text] [Related]
7. Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).
Gonschior AK; Christians U; Braun F; Winkler M; Linck A; Baumann J; Sewing KF
Br J Clin Pharmacol; 1994 Dec; 38(6):567-71. PubMed ID: 7534100
[TBL] [Abstract][Full Text] [Related]
8. A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents.
MacFarlane G; Scheller D; Ersfeld D; Jensen T; Jevans A; Wong PY; Kobayashi M
Ther Drug Monit; 1996 Dec; 18(6):698-705. PubMed ID: 8946668
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study.
Liu C; Shang YF; Zhang XF; Zhang XG; Wang B; Wu Z; Liu XM; Yu L; Ma F; Lv Y
Eur J Clin Pharmacol; 2009 Sep; 65(9):881-5. PubMed ID: 19629461
[TBL] [Abstract][Full Text] [Related]
10. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
Hedayat S; Kershner RP; Su G
J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
[TBL] [Abstract][Full Text] [Related]
11. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation.
Kershner RP; Fitzsimmons WE
Transplantation; 1996 Oct; 62(7):920-6. PubMed ID: 8878385
[TBL] [Abstract][Full Text] [Related]
12. Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy.
Shimada T; Terada A; Yokogawa K; Kaneko H; Nomura M; Kaji K; Kaneko S; Kobayashi K; Miyamoto K
Transplantation; 2002 Nov; 74(10):1419-24. PubMed ID: 12451243
[TBL] [Abstract][Full Text] [Related]
13. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.
MacFarlane GD; Scheller DG; Ersfeld DL; Shaw LM; Venkatarmanan R; Sarkozi L; Mullins R; Fox BR
Clin Chem; 1999 Sep; 45(9):1449-58. PubMed ID: 10471647
[TBL] [Abstract][Full Text] [Related]
14. Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.
MacFarlane GD; Shaw LM; Venkataramanan R; Mullins R; Scheller DG; Ersfeld DL
Ther Drug Monit; 1999 Dec; 21(6):585-92. PubMed ID: 10604816
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Maciej K; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2018 Sep; 50(7):2235-2239. PubMed ID: 30177142
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between MDR1 gene polymorphism and blood concentration of tacrolimus in renal transplant patients].
Wang W; Zhang XD; Ma LL; Lü YP; Hu XP; Zhang P; Wang Y; Guan DL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3277-81. PubMed ID: 16409819
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.
Gonschior AK; Christians U; Winkler M; Linck A; Baumann J; Sewing KF
Clin Chem; 1996 Sep; 42(9):1426-32. PubMed ID: 8787699
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus metabolite cross-reactivity in different tacrolimus assays.
Murthy JN; Davis DL; Yatscoff RW; Soldin SJ
Clin Biochem; 1998 Nov; 31(8):613-7. PubMed ID: 9876892
[TBL] [Abstract][Full Text] [Related]
20. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
